Analytical method cross validation by HPLC for identification of five markers and quantification of one marker in SynacinnTM formulations and its in vivo bone marrow micronucleus test data
A HPLC method has been validated for identifying five markers (gallic acid, rosmarinic acid, catechin, andrographolide and curcumin) and quantifying curcumin in SynacinnTM formulation. The validation (bracketed strengths of 10 mg/mL and 100 mg/mL) involved assessment of selectivity, precision, Limit...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-06-01
|
Series: | Data in Brief |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352340921002857 |
id |
doaj-c37882a4917c4cbc98aeeac952fc3142 |
---|---|
record_format |
Article |
spelling |
doaj-c37882a4917c4cbc98aeeac952fc31422021-06-27T04:37:53ZengElsevierData in Brief2352-34092021-06-0136107001Analytical method cross validation by HPLC for identification of five markers and quantification of one marker in SynacinnTM formulations and its in vivo bone marrow micronucleus test dataSiti Nurazwa Zainol0Anis Fadhlina1Sri Vijaya Rentala2Renuka Pillai3Manjula Yalaka4Indu Bansal5Earati Surender6Leela Krishna Vatsavai7Rajesh Eswarappa8Hassan Fahmi Ismail9Fadzilah Adibah Abdul Majid10Proliv Life Sciences Sdn Bhd, D-15, Residensi Bistaria, Jln Ulu Kelang, Taman Ukay Bistari, Ampang, Selangor Darul Ehsan 68000, MalaysiaInstitute of Marine Biotechnology, Universiti Malaysia Terengganu, Kuala Nerus, Terengganu Darul Iman 21030, Malaysia; Faculty of Pharmacy, International Islamic University Malaysia, Bandar Indera Mahkota, Kuantan, Pahang 25200, MalaysiaAurigene Pharmaceutical Services Limited, Bollaram Road, Miyapur, Hyderabad, Telangana 500049, IndiaAurigene Pharmaceutical Services Limited, Bollaram Road, Miyapur, Hyderabad, Telangana 500049, IndiaAurigene Pharmaceutical Services Limited, Bollaram Road, Miyapur, Hyderabad, Telangana 500049, IndiaAurigene Pharmaceutical Services Limited, Bollaram Road, Miyapur, Hyderabad, Telangana 500049, IndiaAurigene Pharmaceutical Services Limited, Bollaram Road, Miyapur, Hyderabad, Telangana 500049, IndiaAurigene Pharmaceutical Services Limited, Bollaram Road, Miyapur, Hyderabad, Telangana 500049, IndiaAurigene Pharmaceutical Services Limited, Bollaram Road, Miyapur, Hyderabad, Telangana 500049, IndiaInstitute of Marine Biotechnology, Universiti Malaysia Terengganu, Kuala Nerus, Terengganu Darul Iman 21030, MalaysiaProliv Life Sciences Sdn Bhd, D-15, Residensi Bistaria, Jln Ulu Kelang, Taman Ukay Bistari, Ampang, Selangor Darul Ehsan 68000, Malaysia; Institute of Marine Biotechnology, Universiti Malaysia Terengganu, Kuala Nerus, Terengganu Darul Iman 21030, Malaysia; Corresponding author.A HPLC method has been validated for identifying five markers (gallic acid, rosmarinic acid, catechin, andrographolide and curcumin) and quantifying curcumin in SynacinnTM formulation. The validation (bracketed strengths of 10 mg/mL and 100 mg/mL) involved assessment of selectivity, precision, Limit of Detection (LOD), Limit of Quantification (LOQ), linearity, accuracy, stability in diluent and formulation stability. Meanwhile, in vivo bone marrow micronucleus test data was presented to evaluate the toxicity potential of Synacinn™ to cause clastogenicity and/or disruption of the mitotic apparatus, as measured by its ability to induce micronucleated polychromatic erythrocytes (MN PCE) in Sprague Dawley rat bone marrow. The test was conducted in two phases viz., Phase I (Dose Range Finding experiment) and Phase II (Definitive experiment). Phase I was conducted to assess general toxicity and bone marrow cytotoxicity of Synacinn™, and to select the doses for the definitive experiment. In-life observations included mortality, clinical signs of toxicity and body weight. Bone marrow samples were collected and extracted from the femur bone using fetal bovine serum. The pellet obtained after the centrifugation was used for preparing bone marrow smears to evaluate the number of immature and mature erythrocytes.http://www.sciencedirect.com/science/article/pii/S2352340921002857Botanical medicineSynacinnTMCurcuminCross validationHPLCClastogenicity |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Siti Nurazwa Zainol Anis Fadhlina Sri Vijaya Rentala Renuka Pillai Manjula Yalaka Indu Bansal Earati Surender Leela Krishna Vatsavai Rajesh Eswarappa Hassan Fahmi Ismail Fadzilah Adibah Abdul Majid |
spellingShingle |
Siti Nurazwa Zainol Anis Fadhlina Sri Vijaya Rentala Renuka Pillai Manjula Yalaka Indu Bansal Earati Surender Leela Krishna Vatsavai Rajesh Eswarappa Hassan Fahmi Ismail Fadzilah Adibah Abdul Majid Analytical method cross validation by HPLC for identification of five markers and quantification of one marker in SynacinnTM formulations and its in vivo bone marrow micronucleus test data Data in Brief Botanical medicine SynacinnTM Curcumin Cross validation HPLC Clastogenicity |
author_facet |
Siti Nurazwa Zainol Anis Fadhlina Sri Vijaya Rentala Renuka Pillai Manjula Yalaka Indu Bansal Earati Surender Leela Krishna Vatsavai Rajesh Eswarappa Hassan Fahmi Ismail Fadzilah Adibah Abdul Majid |
author_sort |
Siti Nurazwa Zainol |
title |
Analytical method cross validation by HPLC for identification of five markers and quantification of one marker in SynacinnTM formulations and its in vivo bone marrow micronucleus test data |
title_short |
Analytical method cross validation by HPLC for identification of five markers and quantification of one marker in SynacinnTM formulations and its in vivo bone marrow micronucleus test data |
title_full |
Analytical method cross validation by HPLC for identification of five markers and quantification of one marker in SynacinnTM formulations and its in vivo bone marrow micronucleus test data |
title_fullStr |
Analytical method cross validation by HPLC for identification of five markers and quantification of one marker in SynacinnTM formulations and its in vivo bone marrow micronucleus test data |
title_full_unstemmed |
Analytical method cross validation by HPLC for identification of five markers and quantification of one marker in SynacinnTM formulations and its in vivo bone marrow micronucleus test data |
title_sort |
analytical method cross validation by hplc for identification of five markers and quantification of one marker in synacinntm formulations and its in vivo bone marrow micronucleus test data |
publisher |
Elsevier |
series |
Data in Brief |
issn |
2352-3409 |
publishDate |
2021-06-01 |
description |
A HPLC method has been validated for identifying five markers (gallic acid, rosmarinic acid, catechin, andrographolide and curcumin) and quantifying curcumin in SynacinnTM formulation. The validation (bracketed strengths of 10 mg/mL and 100 mg/mL) involved assessment of selectivity, precision, Limit of Detection (LOD), Limit of Quantification (LOQ), linearity, accuracy, stability in diluent and formulation stability. Meanwhile, in vivo bone marrow micronucleus test data was presented to evaluate the toxicity potential of Synacinn™ to cause clastogenicity and/or disruption of the mitotic apparatus, as measured by its ability to induce micronucleated polychromatic erythrocytes (MN PCE) in Sprague Dawley rat bone marrow. The test was conducted in two phases viz., Phase I (Dose Range Finding experiment) and Phase II (Definitive experiment). Phase I was conducted to assess general toxicity and bone marrow cytotoxicity of Synacinn™, and to select the doses for the definitive experiment. In-life observations included mortality, clinical signs of toxicity and body weight. Bone marrow samples were collected and extracted from the femur bone using fetal bovine serum. The pellet obtained after the centrifugation was used for preparing bone marrow smears to evaluate the number of immature and mature erythrocytes. |
topic |
Botanical medicine SynacinnTM Curcumin Cross validation HPLC Clastogenicity |
url |
http://www.sciencedirect.com/science/article/pii/S2352340921002857 |
work_keys_str_mv |
AT sitinurazwazainol analyticalmethodcrossvalidationbyhplcforidentificationoffivemarkersandquantificationofonemarkerinsynacinntmformulationsanditsinvivobonemarrowmicronucleustestdata AT anisfadhlina analyticalmethodcrossvalidationbyhplcforidentificationoffivemarkersandquantificationofonemarkerinsynacinntmformulationsanditsinvivobonemarrowmicronucleustestdata AT srivijayarentala analyticalmethodcrossvalidationbyhplcforidentificationoffivemarkersandquantificationofonemarkerinsynacinntmformulationsanditsinvivobonemarrowmicronucleustestdata AT renukapillai analyticalmethodcrossvalidationbyhplcforidentificationoffivemarkersandquantificationofonemarkerinsynacinntmformulationsanditsinvivobonemarrowmicronucleustestdata AT manjulayalaka analyticalmethodcrossvalidationbyhplcforidentificationoffivemarkersandquantificationofonemarkerinsynacinntmformulationsanditsinvivobonemarrowmicronucleustestdata AT indubansal analyticalmethodcrossvalidationbyhplcforidentificationoffivemarkersandquantificationofonemarkerinsynacinntmformulationsanditsinvivobonemarrowmicronucleustestdata AT earatisurender analyticalmethodcrossvalidationbyhplcforidentificationoffivemarkersandquantificationofonemarkerinsynacinntmformulationsanditsinvivobonemarrowmicronucleustestdata AT leelakrishnavatsavai analyticalmethodcrossvalidationbyhplcforidentificationoffivemarkersandquantificationofonemarkerinsynacinntmformulationsanditsinvivobonemarrowmicronucleustestdata AT rajesheswarappa analyticalmethodcrossvalidationbyhplcforidentificationoffivemarkersandquantificationofonemarkerinsynacinntmformulationsanditsinvivobonemarrowmicronucleustestdata AT hassanfahmiismail analyticalmethodcrossvalidationbyhplcforidentificationoffivemarkersandquantificationofonemarkerinsynacinntmformulationsanditsinvivobonemarrowmicronucleustestdata AT fadzilahadibahabdulmajid analyticalmethodcrossvalidationbyhplcforidentificationoffivemarkersandquantificationofonemarkerinsynacinntmformulationsanditsinvivobonemarrowmicronucleustestdata |
_version_ |
1721358678854991872 |